Creative Planning
- SEC CIK
- 0001540235
- Latest filing
- Aug 13, 2026
ZNTL holding history
Zentalis Pharmaceuticals, Inc. in every 13F filed by Creative Planning, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ZNTL overviewAll 13F holders of ZNTLFull Q2 2026 holdings
- Shares (Q2 2026)
- 285,000
- Value
- $1.38M
- % of portfolio
- <0.1%
- Quarters held
- 11
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 285,000 | $1.38M | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 285,000 | $666.9K | <0.1% | +25,000+9.6% | Added | Holders |
| Q4 2025 | 260,000 | $351.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 260,000 | $392.6K | <0.1% | +229,660+757.0% | Added | Holders |
| Q2 2025 | 30,340 | $35.2K | <0.1% | −206,183−87.2% | Reduced | Holders |
| Q1 2025 | 236,523 | $376.1K | <0.1% | +196,420+489.8% | Added | Holders |
| Q4 2024 | 40,103 | $121.5K | <0.1% | +28,803+254.9% | Added | Holders |
| Q3 2024 | 11,300 | $41.6K | <0.1% | −2,099−15.7% | Reduced | Holders |
| Q2 2024 | 13,399 | $54.8K | <0.1% | +1,809+15.6% | Added | Holders |
| Q1 2024 | 11,590 | $182.7K | <0.1% | +590+5.4% | Added | Holders |
| Q4 2023 | 11,000 | $166.7K | <0.1% | +11,000 | New | Holders |